HomeWAVE • CVE
add
Waverley Pharma Inc
Previous close
$0.015
Day range
$0.010 - $0.010
Year range
$0.010 - $0.035
Market cap
405.00K CAD
Avg Volume
7.73K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 452.96K | 829.62% |
Operating expense | 302.50K | -24.64% |
Net income | -65.21K | 95.11% |
Net profit margin | -14.40 | 99.47% |
Earnings per share | — | — |
EBITDA | -82.25K | 77.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 235.93K | 345.02% |
Total assets | 2.05M | 114.83% |
Total liabilities | 4.08M | 95.18% |
Total equity | -2.03M | — |
Shares outstanding | 54.00M | — |
Price to book | -0.38 | — |
Return on assets | -13.46% | — |
Return on capital | -26.05% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -65.21K | 95.11% |
Cash from operations | -94.44K | 80.42% |
Cash from investing | 100.00 | — |
Cash from financing | 84.76K | -83.18% |
Net change in cash | -3.37K | -115.71% |
Free cash flow | -161.78K | 69.59% |
About
Founded
2014
Headquarters
Website
